When?, page-23

however, there could be an injection of funds any day IMO.....
Marc Voight, in answer to a question at end of last webinar said management
were mindful of the size of Immutep and as such there were no plans to expand
on current trial indications.......I have said previously that I took that to mean
current funding limited any further trial starts at this stage.....
OK,
What does that say to me?.....We cant afford to do anymore than we are doing now....
OK, what does that say to Merck, Pfizer etc?....We can't afford to do anymore than
we are doing now so if you want to go to different places in combo trials it's up to
you to provide the funds and we'll consider it......
This is just my opinion.....